American Regent reported on Thursday the availability of Hydroxyprogesterone Caproate Injection, USP in a 250 mg/ml, 1ml preservative free Single Dose Vial to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
The company added the US FDA approved Hydroxyprogesterone Caproate Injection, USP is the only preservative free generic alternative to Makena.
In conjunction, Hydroxyprogesterone Caproate Injection, USP can be ordered through wholesalers/distributors within the next several days,said the company.
With a history in generic specialty injectables, the company is engaged in the development, manufacturing and sales of generic and branded IV products.
Perrigo awarded US FDA tentative approval for first to file generic Ultravate Lotion 0.05%
Indivior PLC unveils PERSERIS once-monthly in the US antipsychotic market
Armas Pharmaceuticals to launch Azacitidine for Injection 100 MG in US
Nexus Pharmaceuticals Receives FDA Approval for Arsenic Trioxide Injection in 10mg per 10mL Vial
Nexus Pharmaceuticals introduces Arsenic Trioxide Injection 10mg per 10mL vial in US
Dr. Reddy's Laboratories unveils Atomoxetine Capsules, USP in the US Market
Mayne Pharma acquires US and Australian rights to halobetasol foam 0.05%
Fresenius Kabi Introduces Leukemia Drug Arsenic Trioxide Injection in 10 mg per 10 mL vial
Breckenridge wins final US FDA approval for Clobazam Tablets ANDA
Teva Formalises North America Headquarters Move with Ceremony in Israel
Amneal to unveil generic Isoproterenol Hydrochloride Injection USP in the US
Amneal passes US FDA approval for marketing Carmustine for Injection USP in 100 mg/vial